tradingkey.logo
tradingkey.logo
検索

Standard BioTools Inc

LAB
ウォッチリストに追加
0.913USD
+0.046+5.32%
終値 07/02, 13:00ET15分遅れの株価
356.16M時価総額
4.57直近12ヶ月PER

詳細情報 Standard BioTools Inc 企業名

Standard BioTools Inc. develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers. The Company's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The Company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. It offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.

Standard BioTools Incの企業情報

企業コードLAB
会社名Standard BioTools Inc
上場日Feb 10, 2011
最高経営責任者「CEO」Egholm (Michael)
従業員数818
証券種類Ordinary Share
決算期末Feb 10
本社所在地2 Tower Place
都市SOUTH SAN FRANCISCO
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号94080
電話番号16502666000
ウェブサイトhttps://www.standardbio.com/
企業コードLAB
上場日Feb 10, 2011
最高経営責任者「CEO」Egholm (Michael)

Standard BioTools Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
757.80K
+65.98%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
222.69K
+44.51%
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Thomas (Tom) Carey
Mr. Thomas (Tom) Carey
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Kathy Hibbs
Ms. Kathy Hibbs
Independent Director
Independent Director
--
--
Mr. Troy Cox
Mr. Troy Cox
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
757.80K
+65.98%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
222.69K
+44.51%
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--

よくある質問

Standard BioTools Incの上位5名の株主は誰ですか?

Standard BioTools Incの上位5名の株主は以下のとおりです。Mr. Sean Mackay

Standard BioTools Inc(LAB)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Standard BioTools Incの株式を保有している機関は342社あり、保有株式の総市場価値は約317.36Mで、全体の81.30%を占めています。2025Q4と比較して、機関の持ち株は773508.00増加しています。

Standard BioTools Incの最大の収益源は何ですか?

2026Q1において、Consumables部門がStandard BioTools Incにとって最大の収益を生み出しており、その金額は36.25Mで、全収益の42.48%を占めています。